Health, finance & everyday support – all in one place
Hand-Picked Story (ad)
Caught on Camera: Trump’s Robot Dog Spotted at Mar-a-Lago
(Behind the Markets)
Editor’s Note: Former tech executive and angel investor Jeff Brown — picked Bitcoin before it jumped as high as 52,400%, Tesla before it jumped as high as 2,150%, and Nvidia before it jumped as high as 32,000%. Today, he’ll show you how to claim a stake in Elon Musk’s upcoming IPO — BEFORE the company goes public.Click here to see the details or read more below.
Last week, while the world watched Artemis and tracked tensions with Iran…
Elon Musk’s team quietly filed paperwork with the SEC.
Not just any paperwork.
The confidential filing for what’s set to bethe largest IPO in history.
Under SEC rules, the public filing could be released any day now.
And when it drops, the frenzy begins.
Bloomberg said the company could seek a valuation of over $1.75 trillion.
That would make it bigger than Saudi Aramco… bigger than any tech IPO ever… bigger than anything Wall Street has ever seen.
CNBC is calling it “the big market event of 2026.”
The New York Times says it will “unleash gushers of cash.”
And what most people don’t know is…
You don’t have to wait for the IPO.
There’s a way to claim your stake TODAY.
Before the public filing drops…
Before millions of investors flood in…
Starting with as little as $500.
See how to get positioned before the announcement.
We have so much to look forward to,
Jeff Brown
Founder & CEO, Brownstone Research TODAY’S BONUS ARTICLE
Ancient Rocks Beneath Canada Are Producing Hydrogen at Massive Scale. A Drug Just Reversed Skin Aging and Tripled Wound Healing Speed. And People Who Lose Weight on Ozempic Face More Social Judgment — Not Less.
A clean energy discovery that could change the hydrogen economy, a dermatology breakthrough that reverses cellular aging in skin, and an unexpected social science finding about GLP-1 drugs.
Ancient Rocks Beneath Canada Are Naturally Producing Hydrogen — at a Scale That Surprised Scientists
Scientists in Canada discovered that ancient underground rock formations — specifically precambrian shield rocks billions of years old — are naturally generating hydrogen gas through a geological process called serpentinization, in which water reacts with iron-bearing minerals deep underground. The scale of production was described as massive and unexpected. The discovery adds Canada to a growing list of locations — including Mali, Oman, and parts of the U.S. — where naturally occurring geological hydrogen has been identified.
Why this matters: hydrogen is considered one of the most promising clean energy carriers, but producing it industrially is expensive and energy-intensive. Natural geological hydrogen — sometimes called “gold hydrogen” — would be far cheaper to extract if it can be accessed at sufficient scale. Several startups are already drilling for it in Mali and the U.S. Midwest. If Canadian reserves prove commercially viable, they would represent a significant addition to the global clean energy supply chain — particularly for industrial processes that are hard to electrify.
The discovery is early-stage in terms of commercial extraction — the scale of the resource doesn’t automatically translate to extractable supply. But the pattern of geological hydrogen discoveries accelerating globally over the past three years is becoming hard to ignore. It’s being watched closely by energy companies and investors who have been skeptical of hydrogen’s commercial future.
A Drug Just Reversed Skin Aging and Tripled the Speed of Wound Healing in Older Tissue
Scientists discovered that a topical drug called ABT-263 — originally developed as a cancer treatment — can dramatically improve wound healing in older skin by removing the senescent “zombie cells” that accumulate with age and impair the skin’s ability to repair itself. In experimental testing, treated older skin showed wound healing speeds roughly three times faster than untreated aged skin, and the treated tissue exhibited markers more consistent with younger skin in terms of collagen production and cellular regeneration.
Wound healing in older adults is a significant medical challenge. Chronic wounds and slow-healing injuries are a leading cause of hospitalization, amputation, and infection-related complications in people over 65. Standard of care has changed little in decades. A drug that clears the cellular debris that blocks healing — rather than just managing the wound surface — represents a mechanistically different approach. ABT-263 is being studied for topical use, which would localize its effects and minimize the systemic risks associated with senolytic drugs when taken systemically.
This connects to the broader senolytic research field — the same category as the Mayo Clinic aptamer work published last week. Clearing senescent cells from aged tissue is emerging as one of the most consistent approaches to reversing localized aging effects. The skin represents one of the most accessible tissues for this kind of intervention.
People Who Lose Weight on Ozempic Face More Social Judgment — Not Less
New research found a counterintuitive social dynamic around GLP-1 weight-loss drugs: people who lose weight using Ozempic or Wegovy may actually face more social judgment than those who lose weight through diet and exercise — or even those who don’t lose weight at all. The stigma appears rooted in a widely held perception that drug-assisted weight loss is somehow less legitimate or less deserved than behavioral change.
The research is notable because it runs counter to the assumption that results speak for themselves. Effective weight loss through any means tends to improve how others perceive someone — but the medication route appears to activate a specific bias around effort and merit that offsets the social benefit of the physical change. This reflects a broader cultural pattern in which the methods used to achieve health outcomes are morally weighted in ways that have no basis in biology.
The practical reality: obesity is a complex metabolic condition with strong genetic and hormonal components. GLP-1 drugs work by addressing biological mechanisms — not by substituting for willpower. The social judgment documented in this research reflects a misunderstanding of how these drugs work and why they’re needed, and it adds a meaningful barrier to people seeking effective treatment for a condition that significantly affects health outcomes.
Also Today→ Nvidia $81.6B — beat by $3B, Q2 guided above $87B consensus — dividend raised 20x from $0.01 to $0.20/share. Free cash flow hit $49B. S&P and Nasdaq opening higher this morning→ Hidden Alzheimer’s trigger identified and disabled — enzyme IDOL, when removed from neurons, sharply reduced amyloid plaques in experimental models. New drug target identified→ Home Depot reports today — after Walmart’s strong results yesterday, the home improvement data tells whether Americans are still investing in their homes or pulling back→ DNA from poop is being used to track and protect one of the world’s rarest marsupials — fewer than 150 Gilbert’s potoroos remain in Australia. Genetic monitoring from fecal samples is tracking individual animals without capture
Sources: ScienceDaily May 19–20, 2026 · Nvidia Q1 FY2027 · GuruFocus · CNBC
Hand-Picked Stories (ads)
The 15-Day Countdown to SpaceX Wealth
(Research Boulevard)
The robot video that terrified engineers
(Disruptors & Dominators)
Elon Just Showed Trump His Army of Robots
(Behind the Markets)
Insursentry.com is provided under the management of Sparks Affiliates, LLC.
Have questions? Contact us at support@insursentry.com
Stop receiving our marketing communications by unsubscribing here .
Privacy Policy
Terms & Conditions
848 Main St Ste 10, Billings, MT 59105.
© 2026 Insursentry. Аll Rights Reserved.
RJ Hamster 